Castro-Santamaria相关文献与解析，生知库

Mannowetz, Nadja; McCallum, Stewart W; Sidhu, Sharan; Mena, Karen H; Ruby, Eric P; Castro-Santamaria, Ramiro; Dodds, Emily; Henderson, Dennis; Whitaker, Gareth; Wright, Heather; Beaudoin, Sarah; Bakshi, Akash

免疫/内分泌

发表日期：2025

文献求助收藏

A randomized, controlled, repeat-dose study of batefenterol/fluticasone furoate compared with placebo in the treatment of COPD

一项随机、对照、重复给药研究，比较了巴特芬特罗/糠酸氟替卡松与安慰剂治疗慢性阻塞性肺疾病的疗效。

期刊:BMC Pulmonary Medicine

影响因子:2.8

doi:10.1186/s12890-020-1153-7

Crim, Courtney; Gotfried, Mark; Spangenthal, Selwyn; Watkins, Michael; Emmett, Amanda; Crawford, Catriona; Baidoo, Charlotte; Castro-Santamaria, Ramiro

慢性阻塞性肺疾病

发表日期：2020

文献求助收藏

Serum cholesterol and risk of high-grade prostate cancer: results from the REDUCE study

血清胆固醇与高危前列腺癌风险：REDUCE 研究的结果

期刊:Prostate Cancer and Prostatic Diseases

影响因子:5.8

doi:10.1038/s41391-017-0030-9

Jamnagerwalla, Juzar; Howard, Lauren E; Allott, Emma H; Vidal, Adriana C; Moreira, Daniel M; Castro-Santamaria, Ramiro; Andriole, Gerald L; Freeman, Michael R; Freedland, Stephen J

Geographic Differences in Baseline Prostate Inflammation and Relationship with Subsequent Prostate Cancer Risk: Results from the Multinational REDUCE Trial

基线前列腺炎症的地域差异及其与后续前列腺癌风险的关系：来自多国REDUCE试验的结果

期刊:Cancer Epidemiology Biomarkers & Prevention

影响因子:3.4

doi:10.1158/1055-9965.EPI-18-0076

Allott, Emma H; Markt, Sarah C; Howard, Lauren E; Vidal, Adriana C; Moreira, Daniel M; Castro-Santamaria, Ramiro; Andriole, Gerald L; Mucci, Lorelei A; Freedland, Stephen J

Immunology/Inflammation

Statin Use, Serum Lipids, and Prostate Inflammation in Men with a Negative Prostate Biopsy: Results from the REDUCE Trial

他汀类药物使用、血脂和前列腺炎症与前列腺活检阴性男性前列腺炎症的关系：REDUCE试验结果

期刊:Cancer Prevention Research

影响因子:2.6

doi:10.1158/1940-6207.CAPR-17-0019

Allott, Emma H; Howard, Lauren E; Vidal, Adriana C; Moreira, Daniel M; Castro-Santamaria, Ramiro; Andriole, Gerald L; Freedland, Stephen J

炎症/感染

Immunology/Inflammation

Racial differences in prostate inflammation: results from the REDUCE study

前列腺炎症的种族差异：REDUCE 研究的结果

期刊:Oncotarget

影响因子:

doi:10.18632/oncotarget.10690

Vidal, Adriana C; Chen, Zinan; Howard, Lauren E; Moreira, Daniel M; Castro-Santamaria, Ramiro; Andriole, Gerald L; Taioli, Emanuela; Fowke, Jay H; Knudsen, Beatrice; Drake, Charles G; Nickel, J Curtis; Freedland, Stephen J

The Association between Phosphodiesterase Type 5 Inhibitors and Prostate Cancer: Results from the REDUCE Study

磷酸二酯酶 5 型抑制剂与前列腺癌的关联：REDUCE 研究的结果

期刊:Journal of Urology

影响因子:6.8

doi:10.1016/j.juro.2016.03.172

Jamnagerwalla, Juzar; Howard, Lauren E; Vidal, Adriana C; Moreira, Daniel M; Castro-Santamaria, Ramiro; Andriole, Gerald L; Freedland, Stephen J

Baseline subject characteristics predictive of compliance with study-mandated prostate biopsy in men at risk of prostate cancer: results from REDUCE

REDUCE 研究结果显示，基线受试者特征可预测前列腺癌高危男性对研究要求的前列腺活检的依从性。

期刊:Prostate Cancer and Prostatic Diseases

影响因子:5.8

doi:10.1038/pcan.2016.5

Fischer, S; Sun, S; Howard, L E; Moreira, D M; Castro-Santamaria, R; Andriole, G L; Vidal, A C; Freedland, S J

Aspirin, NSAIDs, and risk of prostate cancer: results from the REDUCE study

阿司匹林、非甾体抗炎药与前列腺癌风险：REDUCE 研究的结果

期刊:Clinical Cancer Research

影响因子:10.2

doi:10.1158/1078-0432.CCR-14-2235

Vidal, Adriana C; Howard, Lauren E; Moreira, Daniel M; Castro-Santamaria, Ramiro; Andriole, Gerald L; Freedland, Stephen J

Metabolic syndrome-like components and prostate cancer risk: results from the Reduction by Dutasteride of Prostate Cancer Events (REDUCE) study

代谢综合征样成分与前列腺癌风险：度他雄胺降低前列腺癌事件（REDUCE）研究的结果

期刊:Bju International

影响因子:4.4

doi:10.1111/bju.12843

Sourbeer, Katharine N; Howard, Lauren E; Andriole, Gerald L; Moreira, Daniel M; Castro-Santamaria, Ramiro; Freedland, Stephen J; Vidal, Adriana C

Safety and pharmacokinetics of the non-hormonal male contraceptive YCT-529

非激素男性避孕药YCT-529的安全性和药代动力学

A randomized, controlled, repeat-dose study of batefenterol/fluticasone furoate compared with placebo in the treatment of COPD

一项随机、对照、重复给药研究，比较了巴特芬特罗/糠酸氟替卡松与安慰剂治疗慢性阻塞性肺疾病的疗效。

Serum cholesterol and risk of high-grade prostate cancer: results from the REDUCE study

血清胆固醇与高危前列腺癌风险：REDUCE 研究的结果

Geographic Differences in Baseline Prostate Inflammation and Relationship with Subsequent Prostate Cancer Risk: Results from the Multinational REDUCE Trial

基线前列腺炎症的地域差异及其与后续前列腺癌风险的关系：来自多国REDUCE试验的结果

Statin Use, Serum Lipids, and Prostate Inflammation in Men with a Negative Prostate Biopsy: Results from the REDUCE Trial

他汀类药物使用、血脂和前列腺炎症与前列腺活检阴性男性前列腺炎症的关系：REDUCE试验结果

Racial differences in prostate inflammation: results from the REDUCE study

前列腺炎症的种族差异：REDUCE 研究的结果

The Association between Phosphodiesterase Type 5 Inhibitors and Prostate Cancer: Results from the REDUCE Study

磷酸二酯酶 5 型抑制剂与前列腺癌的关联：REDUCE 研究的结果

Baseline subject characteristics predictive of compliance with study-mandated prostate biopsy in men at risk of prostate cancer: results from REDUCE

REDUCE 研究结果显示，基线受试者特征可预测前列腺癌高危男性对研究要求的前列腺活检的依从性。

Aspirin, NSAIDs, and risk of prostate cancer: results from the REDUCE study

阿司匹林、非甾体抗炎药与前列腺癌风险：REDUCE 研究的结果

Metabolic syndrome-like components and prostate cancer risk: results from the Reduction by Dutasteride of Prostate Cancer Events (REDUCE) study

代谢综合征样成分与前列腺癌风险：度他雄胺降低前列腺癌事件（REDUCE）研究的结果